In series:OECD Series on Testing and Assessmentview more titles
Published on September 03, 2014
This document describes the state of knowledge of the adverse outcome pathway (AOP)
for skin sensitisation initiated by covalent binding to proteins, assesses the weight-of-evidence
supporting the AOP, identifies the key events, and identifies databases containing
test results related to those key events. AOPs can be incorporated into chemical categories-based
assessments or integrated approaches for testing and assessment.